Effect of Eladigana Choorna on Reducing Hyperpigmentation in Postpartum Women

A SINGLE ARM CLINICAL STUDY TO EVALUATE THE EFFECT OF ELADIGANA CHOORNA ON CHLOASMA IN POSTPARTUM WOMEN - NIL

Status

Active, not recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2025/05/086683

Enrollment

Registered

2025-05-09

Start date

Unknown

Completion date

Unknown

Last updated

2025-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L811- Chloasma

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: Postpartum women with hyperpigmentation developed during pregnancy Age more then 19 yrs. Patients who clear the sensitivity test Patient with MASI index score moreqthen 4

Exclusion criteria

Exclusion criteria: Patient with any skin disease such as Psoriasis, Eczema, Skin cancer, wound in the hyper-pigmented area. Patients who are allergic to the study drug. Patient using any cosmetic products on the face Patient not willing to stop the usage of face wash, moisturizer, or any other skin products during the course of treatment

Design outcomes

Primary

Measure	Time frame
Reduction in the severity of chloasma in terms of darkness, area, and homogeneity assessed through MASI Index score and Improvement of skin color assessed through Color probe of DermaLab combo. Timepoint: Day 1: Pre assessment screening and admission for the course of 2 weeks. Day 15: post assessment and result	—

Secondary

Measure	Time frame
NILTimepoint: NIL	—

Countries

India

Contacts

Public ContactRadhika Chauhan

Amrita School of Ayurveda

dr.anjaly@ay.amrita.edu9495114149

Outcome results